TO THE PROMISSORY NOTE DATED December 14, 2017Biolargo, Inc. • September 18th, 2018 • Chemicals & allied products
The Parties entered into a 5% Convertible Note Dated December 14, 2017 in the Original Principal Amount of $500,000, as amended December 18, 2017, security number BLGO-1-33081 (the “Note”) by and between BioLargo, Inc. (“Company”) and Vista Capital Investments, LLC (“Holder”) (together referred to as the “Parties”).
COMMON STOCK PURCHASE WARRANT BIOLARGO, INC.Common Stock Purchase Warrant • September 18th, 2018 • Biolargo, Inc. • Chemicals & allied products • Nevada
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (as part of a fee in connection with the extension amendment dated September 12, 2018 attached hereto as “Exhibit C”, amending the convertible note in the original principal amount of $500,000.00 (the “Note”), to Vista Capital Investments, LLC (including any permitted and registered assigns, the “Holder”) on December 14, 2017), the Holder is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from BioLargo, Inc., a Delaware corporation (the “Company”), 1,812,000 shares of Common Stock (as defined below) (the “Warrant Shares”) at the Exercise Price per share then in effect (whereby such numbers may be adjusted from time to time pursuant to the terms and conditions of this Warrant).
